In JIA pre-treatment the MIGS expression in CD14+ monocytes was less than in JDM pre-treatment compared to the same controls (estimate=3.62,95%CI(3.22,4.02),p-value<2.2e-16). Here, CD14 is linked to juvenile idiopathic arthritis.